Reducing the global burden of HTLV-1 infection: An agenda for research and action

Antiviral Research

Volumn 137, Issue , 2017, Pages 41-48

  Willems, Luc ^a,z   Hasegawa, Hideki ^b,z   Accolla, Roberto ^c   Bangham, Charles ^d   Bazarbachi, Ali ^e   Bertazzoni, Umberto ^f   Carneiro Proietti, Anna Barbara de Freitas ^g   Cheng, Hua ^h   Chieco Bianchi, Luigi ⁱ   Ciminale, Vincenzo ⁱ   Coelho dos Reis, Jordana ^j   Esparza, José ^h   Gallo, Robert C ^h   Gessain, Antoine ^k   Gotuzzo, Eduardo ^l   Hall, William ^m   Harford, Joseph ⁿ   Hermine, Olivier ^o   Jacobson, Steven ^p   Macchi, Beatrice ^q   Macpherson, Calum ^r   Mahieux, Renaud ^s   Matsuoka, Masao ^t   Murphy, Edward ^u   Peloponese, Jean Marie ^v   Simon, Viviana ^w   Tagaya, Yutaka ^h   Taylor, Graham P ^d   Watanabe, Toshiki ^x   Yamano, Yoshihisa ^y   more..

^a UNIVERSITY OF LIÈGE   (Belgium)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^c UNIVERSITY OF INSUBRIA   (Italy)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

^e AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^f UNIVERSITY OF VERONA   (Italy)

^g FUNDAÇÃO HEMOMINAS   (Brazil)

^h INSTITUTE OF HUMAN VIROLOGY   (United States)

ⁱ UNIVERSITY OF PADOVA   (Italy)

^j INSTITUTO OSWALDO CRUZ   (Brazil)

^k INSTITUT PASTEUR   (France)

^l INSTITUTO DE MEDICINA TROPICAL ALEXANDER VON HUMBOLDT   (Peru)

^m Centre for Research in Infectious Disease   (Ireland)

ⁿ NATIONAL CANCER INSTITUTE   (United States)

^o HÔPITAL NECKER ENFANTS MALADES   (France)

^p NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^q UNIVERSITY OF ROME TOR VERGATA   (Italy)

^r ST GEORGE S UNIVERSITY   (Grenada)

^s UNIVERSITÉ DE LYON   (France)

^t KYOTO UNIVERSITY   (Japan)

^u UNIVERSITY OF CALIFORNIA   (United States)

^v UNIV MONTPELLIER   (France)

^w MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^x UNIVERSITY OF TOKYO   (Japan)

^y ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^z Chairs of the HTLV Taskforce of the Global Virus Network   (United States)

more..

Author keywords

HTLV 1; Leukemia; Oncogene; Retrovirus; Vaccine

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

DISEASE COURSE; DISEASE TRANSMISSION; HTLV-1 INFECTION; HUMAN; HUMAN T CELL LEUKEMIA VIRUS; PATHOGENESIS; PREDICTION; PRIORITY JOURNAL; RESEARCH PRIORITY; REVIEW; T CELL LEUKEMIA; TROPICAL SPASTIC PARAPARESIS; ADVISORY COMMITTEE; COST OF ILLNESS; GLOBAL HEALTH; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN T-LYMPHOTROPIC VIRUS 1; ISOLATION AND PURIFICATION; MEDICAL RESEARCH; SPINAL CORD DISEASE; TRANSMISSION; VIROLOGY;

ADVISORY COMMITTEES; BIOMEDICAL RESEARCH; COST OF ILLNESS; GLOBAL HEALTH; HIV INFECTIONS; HTLV-I INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; LEUKEMIA-LYMPHOMA, ADULT T-CELL; PARAPARESIS, TROPICAL SPASTIC; SPINAL CORD DISEASES;

EID: 85002245143     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2016.10.015     Document Type: Review

References (30)

1. Asquith, B., Bangham, C.R.M., How does HTLV-I persist despite a strong cell-mediated immune response?. Trends Immunol. 29 (2008), 4–11, 10.1016/j.it.2007.09.006.
2. Bangham, C.R.M., Araujo, A., Yamano, Y., Taylor, G.P., HTLV-1-associated myelopathy/tropical spastic paraparesis. Nat. Rev. Dis. Prim., 1, 2015, 15012, 10.1038/nrdp.2015.12.
3. Bazarbachi, A., Plumelle, Y., Ramos, J.C., Tortevoye, P., Otrock, Z., Taylor, G., Gessain, A., Harrington, W., Panelatti, G., Hermine, O., Meta-analysis on the use of zidovudine and interferon-alfa in adult T-cell leukemia/lymphoma showing improved survival in the leukemic subtypes. J. Clin. Oncol. 28 (2010), 4177–4183, 10.1200/JCO.2010.28.0669.
4. Boxus, M., Twizere, J.C., Legros, S., Kettmann, R., Willems, L., Interaction of HTLV-1 Tax with minichromosome maintenance proteins accelerates the replication timing program. Blood 119 (2012), 151–160, 10.1182/blood-2011-05-356790.
5. Calattini, S., Chevalier, S.A., Duprez, R., Afonso, P., Froment, A., Gessain, A., Mahieux, R., Human T-cell lymphotropic virus type 3: complete nucleotide sequence and characterization of the human tax3 protein. J. Virol. 80 (2006), 9876–9888, 10.1128/JVI.00799-06.
6. de Brogniez, A., Bouzar, A.B., Jacques, J.-R., Cosse, J.-P., Gillet, N., Callebaut, I., Reichert, M., Willems, L., Mutation of a single envelope N-Linked glycosylation site enhances the pathogenicity of bovine leukemia virus. J. Virol. 89 (2015), 8945–8956, 10.1128/JVI.00261-15.
7. Enose-Akahata, Y., Caruso, B., Haner, B., Charlip, E., Nair, G., Massoud, R., Billioux, B.J., Ohayon, J., Switzer, W.M., Jacobson, S., Development of neurologic diseases in a patient with primate T lymphotropic virus type 1 (PTLV-1). Retrovirology, 13, 2016, 56, 10.1186/s12977-016-0290-9.
8. Filippone, C., Betsem, E., Tortevoye, P., Cassar, O., Bassot, S., Froment, A., Fontanet, A., Gessain, A., A severe bite from a nonhuman primate is a major risk factor for HTLV-1 infection in hunters from central Africa. Clin. Infect. Dis., 2015, 1–10, 10.1093/cid/civ145.
9. Gabet, A.-S., Mortreux, F., Talarmin, A., Plumelle, Y., Leclercq, I., Leroy, A., Gessain, A., Clity, E., Joubert, M., Wattel, E., High circulating proviral load with oligoclonal expansion of HTLV-1 bearing T cells in HTLV-1 carriers with strongyloidiasis. Oncogene 19 (2000), 4954–4960, 10.1038/sj.onc.1203870.
10. Gessain, A., Cassar, O., Epidemiological aspects and world distribution of HTLV-1 infection. Front. Microbiol. 3 (2012), 1–23, 10.3389/fmicb.2012.00388.
11. Ghez, D., Lepelletier, Y., Jones, K.S., Pique, C., Hermine, O., Current concepts regarding the HTLV-1 receptor complex. Retrovirology, 7, 2010, 99, 10.1186/1742-4690-7-99.
12. Gillet, N.A., Malani, N., Melamed, A., Gormley, N., Carter, R., Bentley, D., Bushman, F.D., Taylor, G.P., Bangham, C.R.M., Dc, W., Berry, C., The host genomic environment of the provirus determines the abundance of HTLV-1 − infected T-cell clones. Blood 117 (2011), 3113–3122, 10.1182/blood-2010-10-312926.
13. Gillet, N.A., Gutiérrez, G., Rodriguez, S.M., de Brogniez, A., Renotte, N., Alvarez, I., Trono, K., Willems, L., Massive depletion of bovine leukemia virus proviral clones located in genomic transcriptionally active sites during primary infection. PLoS Pathog., 9, 2013, e1003687, 10.1371/journal.ppat.1003687.
14. Gonçalves, D.U., Proietti, F.A., Ribas, J.G.R., Araujo, M.G., Pinheiro, S.R., Guedes, A.C., Carneiro-Proietti, A.B.F., Epidemiology, treatment, and prevention of human T-cell leukemia virus type 1-associated diseases. Clin. Microbiol. Rev. 23 (2010), 577–589, 10.1128/CMR.00063-09.
15. Gutiérrez, G., Rodríguez, S.M., De Brogniez, A., Gillet, N., Golime, R., Burny, A., Jaworski, J.P., Alvarez, I., Vagnoni, L., Trono, K., Willems, L., Vaccination against δ-retroviruses: the bovine leukemia virus paradigm. Viruses 6 (2014), 2416–2427, 10.3390/v6062416.
16. Kataoka, K., Nagata, Y., Kitanaka, A., Shiraishi, Y., Shimamura, T., Yasunaga, J., Totoki, Y., Chiba, K., Sato-Otsubo, A., Nagae, G., Ishii, R., Muto, S., Kotani, S., Watatani, Y., Takeda, J., Sanada, M., Tanaka, H., Suzuki, H., Sato, Y., Shiozawa, Y., Yoshizato, T., Yoshida, K., Makishima, H., Iwanaga, M., Ma, G., Nosaka, K., Hishizawa, M., Itonaga, H., Imaizumi, Y., Munakata, W., Ogasawara, H., Sato, T., Sasai, K., Muramoto, K., Penova, M., Kawaguchi, T., Nakamura, H., Hama, N., Shide, K., Kubuki, Y., Hidaka, T., Kameda, T., Nakamaki, T., Ishiyama, K., Miyawaki, S., Yoon, S.-S., Tobinai, K., Miyazaki, Y., Takaori-Kondo, A., Matsuda, F., Takeuchi, K., Nureki, O., Aburatani, H., Watanabe, T., Shibata, T., Matsuoka, M., Miyano, S., Shimoda, K., Ogawa, S., Integrated molecular analysis of adult T cell leukemia/lymphoma. Nat. Genet., 2015, 10.1038/ng.3415.
17. Kato, K., Akashi, K., Recent advances in therapeutic approaches for adult T-cell leukemia/lymphoma. Viruses 7 (2015), 6604–6612, 10.3390/v7122960.
18. Kchour, G., Rezaee, R., Farid, R., Ghantous, A., Rafatpanah, H., Tarhini, M., Kooshyar, M.M., El Hajj, H., Berry, F., Mortada, M., Nasser, R., Shirdel, A., Dassouki, Z., Ezzedine, M., Rahimi, H., Ghavamzadeh, A., de The, H., Hermine, O., Mahmoudi, M., Bazarbachi, A., The combination of arsenic, interferon-alpha, and zidovudine restores an “immunocompetent-like” cytokine expression profile in patients with adult T-cell leukemia lymphoma. Retrovirology, 10, 2013, 91, 10.1186/1742-4690-10-91.
19. Martin, F., Taylor, G.P., Jacobson, S., Inflammatory manifestations of HTLV-1 and their therapeutic options. Expert Rev. Clin. Immunol. 10 (2014), 1531–1546, 10.1586/1744666X.2014.966690.
20. Matsuoka, M., Jeang, K.-T., Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation. Nat. Rev. Cancer 7 (2007), 270–280, 10.1038/nrc2111.
21. McSweegan, E., Weaver, S.C., Lecuit, M., Frieman, M., Morrison, T.E., Hrynkow, S., The global virus Network: challenging chikungunya. Antivir. Res. 120 (2015), 147–152, 10.1016/j.antiviral.2015.06.003.
22. Murphy, E.L., Infection with human T-lymphotropic virus types-1 and -2 (HTLV-1 and -2): implications for blood transfusion safety. Transfus. Clin. Biol. J. Société Fr. Transfus. Sang. 23 (2016), 13–19, 10.1016/j.tracli.2015.12.001.
23. Olindo, S., Belrose, G., Gillet, N., Rodriguez, S., Boxus, M., Verlaeten, O., Asquith, B., Bangham, C., Signate, A., Smadja, D., Lezin, A., Cesaire, R., Willems, L., Brief report Safety of long-term treatment of HAM/TSP patients with valproic acid. Blood 118 (2011), 6306–6309, 10.1182/blood-2011-04-349910.
24. Pique, C., Jones, K.S., Pathways of cell-cell transmission of HTLV-1. Front. Microbiol. 3 (2012), 1–14, 10.3389/fmicb.2012.00378.
25. Richard, L., Mouinga-Ondémé, A., Betsem, E., Filippone, C., Nerrienet, E., Kazanji, M., Gessain, A., Zoonotic transmission of two new strains of human T-lymphotropic virus type 4 in hunters bitten by a Gorilla in central Africa. Clin. Infect. Dis., 2016, 1–4, 10.1093/cid/ciw389 ahead of p.
26. Sibon, D., Gabet, A.S., Zandecki, M., Pinatel, C., Thête, J., Delfau-Larue, M.H., Rabaaoui, S., Gessain, A., Gout, O., Jacobson, S., Mortreux, F., Wattel, E., HTLV-1 propels untransformed CD4+ lymphocytes into the cell cycle while protecting CD8+ cells from death. J. Clin. Investig. 116 (2006), 974–983, 10.1172/JCI27198.
27. Suehiro, Y., Hasegawa, A., Iino, T., Sasada, A., Watanabe, N., Matsuoka, M., Takamori, A., Tanosaki, R., Utsunomiya, A., Choi, I., Fukuda, T., Miura, O., Takaishi, S., Teshima, T., Akashi, K., Kannagi, M., Uike, N., Okamura, J., Clinical outcomes of a novel therapeutic vaccine with Tax peptide-pulsed dendritic cells for adult T cell leukaemia/lymphoma in a pilot study. Br. J. Haematol. 169 (2015), 356–367, 10.1111/bjh.13302.
28. Tsukasaki, K., Hermine, O., Bazarbachi, A., Ratner, L., Ramos, J.C., Harrington, W., O'Mahony, D., Janik, J.E., Bittencourt, A.L., Taylor, G.P., Yamaguchi, K., Utsunomiya, A., Tobinai, K., Watanabe, T., Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma: a proposal from an international consensus meeting. J. Clin. Oncol. 27 (2009), 453–459, 10.1200/JCO.2008.18.2428.
29. Tsukasaki, K., Tobinai, K., Human T-cell lymphotropic virus type I-associated adult T-cell leukemia-lymphoma: new directions in clinical research. Clin. Cancer Res. 20 (2014), 5217–5225, 10.1158/1078-0432.CCR-14-0572.
30. Yamagishi, M., Nakano, K., Miyake, A., Yamochi, T., Kagami, Y., Tsutsumi, A., Matsuda, Y., Sato-Otsubo, A., Muto, S., Utsunomiya, A., Yamaguchi, K., Uchimaru, K., Ogawa, S., Watanabe, T., Polycomb-mediated loss of miR-31 activates nik-dependent NF-κB pathway in adult T cell leukemia and other cancers. Cancer Cell 21 (2012), 121–135, 10.1016/j.ccr.2011.12.015.